首页> 外文期刊>Hepato-gastroenterology. >The accumulating appreciation of endoscopic submucosal dissection in the treatment of gastrointestinal neoplasms: Preliminary experience in local Eastern China
【24h】

The accumulating appreciation of endoscopic submucosal dissection in the treatment of gastrointestinal neoplasms: Preliminary experience in local Eastern China

机译:内镜下黏膜下剥离术在消化道肿瘤治疗中的积累价值:在华东地区的初步经验

获取原文
获取原文并翻译 | 示例
           

摘要

Background/aims: Endoscopic submucosal dissection (ESD), an emerging technique originated from Japan, has been introduced into China in recent years. The aim of this study was to evaluate the efficacy and safety of ESD in the treatment of gastrointestinal (Gl) neoplasms. Methodology: Early GI neoplasms (n=41) in 40 patients from local Eastern China were treated with ESD at Zhejiang Provincial People's Hospital and followed-up from January 2009 to December 2011. Postoperative pathology, complications and therapeutic outcomes were retrospectively analyzed. Results: Mean size of the resected lesions was 2.2±0.81cm (1.2-6.0cm) and mean operation time was 77±28 minutes (20-150 minutes). The rates for successful resection, en bloc resection and complications were 90.2% (37/41), 83.8% (31/37) and 9.8% (4/41), respectively. The postoperative pathology showed 4 cases of early esophageal cancer, 6 of early gastric cancer or high-grade intraepithelial neoplastic changes, 5 of rectal laterally spreading tumor, 5 of esophageal or gastric leiomyoma, 2 of gastric heterotopic pancreas, and 18 of esophageal and gastric flat lesions with low-grade intraepithelial neoplastic changes. Tumor residue or recurrence was not been detected in all 40 patients during follow-up. Conclusions: According to our experience in local Eastern China, ESD is a feasible technique for the treatment of GI neoplasms. Even though it has promising resection rate and acceptable complication rate, the indication of ESD should be selected strictly and the operators need to be well-trained.
机译:背景/目的:内窥镜黏膜下剥离术(ESD)是一种起源于日本的新兴技术,近年来已被引入中国。这项研究的目的是评估ESD在胃肠道(G1)肿瘤治疗中的功效和安全性。方法:2009年1月至2011年12月,在浙江省人民医院对40例华东地区的早期胃肠肿瘤(n = 41)进行了ESD治疗,并进行了随访。对术后病理,并发症和治疗结果进行回顾性分析。结果:切除的病变平均大小为2.2±0.81cm(1.2-6.0cm),平均手术时间为77±28分钟(20-150分钟)。成功切除,整体切除和并发症的发生率分别为90.2%(37/41),83.8%(31/37)和9.8%(4/41)。术后病理显示4例早期食管癌,6例早期胃癌或高度上皮内肿瘤改变,5例直肠侧向扩散性肿瘤,5例食管或胃平滑肌瘤,2例胃异位胰腺,18例食管和胃扁平病灶伴低度上皮内瘤变。在随访期间未在所有40例患者中检测到肿瘤残留或复发。结论:根据我们在中国东部地区的经验,ESD是一种治疗胃肠道肿瘤的可行技术。尽管它具有良好的切除率和可接受的并发症发生率,但仍应严格选择ESD的适应症,并且操作人员必须接受良好的培训。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号